Katherine L. Harper

5.0k total citations
23 papers, 1.0k citations indexed

About

Katherine L. Harper is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Katherine L. Harper has authored 23 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Immunology. Recurrent topics in Katherine L. Harper's work include RNA modifications and cancer (5 papers), Viral-associated cancers and disorders (4 papers) and T-cell and B-cell Immunology (4 papers). Katherine L. Harper is often cited by papers focused on RNA modifications and cancer (5 papers), Viral-associated cancers and disorders (4 papers) and T-cell and B-cell Immunology (4 papers). Katherine L. Harper collaborates with scholars based in United Kingdom, South Africa and France. Katherine L. Harper's co-authors include Marie‐Geneviève Mattéi, Pierre Golstein, Éric Rouvier, M F Luciani, Marcus Pembrey, Adrian Whitehouse, Nadia Abdel Wahab, Roger M. Mason, R M Winter and Edward G. D. Tuddenham and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Nature Communications.

In The Last Decade

Katherine L. Harper

21 papers receiving 993 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine L. Harper United Kingdom 16 418 384 301 158 101 23 1.0k
Tina Haliotis Canada 15 306 0.7× 525 1.4× 131 0.4× 201 1.3× 45 0.4× 32 960
Fatima Dhalla United Kingdom 14 210 0.5× 439 1.1× 152 0.5× 105 0.7× 42 0.4× 20 794
Roxanne Fischer United States 17 471 1.1× 368 1.0× 330 1.1× 105 0.7× 21 0.2× 21 984
William T. Yewdell United States 15 612 1.5× 431 1.1× 96 0.3× 154 1.0× 67 0.7× 23 1.3k
Enguerran Mouly France 11 519 1.2× 286 0.7× 154 0.5× 173 1.1× 106 1.0× 15 907
Alexandros Onoufriadis United Kingdom 16 375 0.9× 357 0.9× 239 0.8× 109 0.7× 27 0.3× 44 1.1k
Laura Woods United States 11 397 0.9× 439 1.1× 100 0.3× 162 1.0× 116 1.1× 16 1.1k
David Klinkebiel United States 18 691 1.7× 320 0.8× 96 0.3× 258 1.6× 163 1.6× 35 1.1k
R Suzuki Japan 10 377 0.9× 236 0.6× 203 0.7× 113 0.7× 89 0.9× 16 799
N Schneider United States 13 723 1.7× 88 0.2× 255 0.8× 211 1.3× 92 0.9× 26 1.3k

Countries citing papers authored by Katherine L. Harper

Since Specialization
Citations

This map shows the geographic impact of Katherine L. Harper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine L. Harper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine L. Harper more than expected).

Fields of papers citing papers by Katherine L. Harper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine L. Harper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine L. Harper. The network helps show where Katherine L. Harper may publish in the future.

Co-authorship network of co-authors of Katherine L. Harper

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine L. Harper. A scholar is included among the top collaborators of Katherine L. Harper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine L. Harper. Katherine L. Harper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Murphy, James C., et al.. (2025). EMG1 methyltransferase activity affects ribosome occupancy at KSHV uORFs. Cell Reports. 44(4). 115516–115516.
2.
Harper, Katherine L., et al.. (2024). Virus-modified paraspeckle-like condensates are hubs for viral RNA processing and their formation drives genomic instability. Nature Communications. 15(1). 10240–10240. 7 indexed citations
3.
Carden, Holli, Katherine L. Harper, Mark Dallas, et al.. (2024). K v 1.3-induced hyperpolarization is required for efficient Kaposi’s sarcoma–associated herpesvirus lytic replication. Science Signaling. 17(845). eadg4124–eadg4124. 3 indexed citations
4.
Baquero-Pérez, Belinda, Katherine L. Harper, Molly R. Patterson, et al.. (2023). m6A Regulates the Stability of Cellular Transcripts Required for Efficient KSHV Lytic Replication. Viruses. 15(6). 1381–1381. 8 indexed citations
5.
Murphy, James C., et al.. (2023). Kaposi’s sarcoma-associated herpesvirus induces specialised ribosomes to efficiently translate viral lytic mRNAs. Nature Communications. 14(1). 300–300. 16 indexed citations
6.
Harper, Katherine L., Chinedu A. Anene, Molly R. Patterson, et al.. (2022). Dysregulation of the miR‐30c/DLL4 axis by circHIPK3 is essential for KSHV lytic replication. EMBO Reports. 23(5). e54117–e54117. 14 indexed citations
7.
Harper, Katherine L., et al.. (2021). Insights into the Evolving Roles of Circular RNAs in Cancer. Cancers. 13(16). 4180–4180. 18 indexed citations
8.
Morgan, Ethan L., Molly R. Patterson, Christopher W. Wasson, et al.. (2020). MicroRNA-18a targeting of the STK4/MST1 tumour suppressor is necessary for transformation in HPV positive cervical cancer. PLoS Pathogens. 16(6). e1008624–e1008624. 55 indexed citations
9.
Harper, Katherine L., et al.. (2019). CircRNAs: From anonymity to novel regulators of gene expression in cancer (Review). International Journal of Oncology. 55(6). 1183–1193. 28 indexed citations
10.
Harper, Katherine L., et al.. (1996). Co-amplification of tail-to-tail copies of MuRVY and IAPE retroviral genomes on the Mus musculus Y Chromosome. Mammalian Genome. 7(1). 31–36. 24 indexed citations
11.
Hakem, Razqallah, et al.. (1991). Differential regulation of HLA-A3 and HLA-B7 MHC class I genes by IFN is due to two nucleotide differences in their IFN response sequences. The Journal of Immunology. 147(7). 2384–2390. 45 indexed citations
12.
Hakem, Razqallah, et al.. (1991). Differential transcription inducibility by interferon of the HLA-A3 and HLA-B7 class-I genes. International Journal of Cancer. 47(S6). 2–9. 5 indexed citations
13.
14.
Harper, Katherine L., Dominique Simon, Marie Suzan, et al.. (1988). Proximity of the CTLA-1 serine esterase and Tcr ? loci in mouse and man. Immunogenetics. 28(6). 439–444. 33 indexed citations
15.
Burn, John, S Povey, Yvonne Boyd, et al.. (1986). Duchenne muscular dystrophy in one of monozygotic twin girls.. Journal of Medical Genetics. 23(6). 494–500. 73 indexed citations
16.
Winter, R M, Katherine L. Harper, E. Goldman, et al.. (1985). First trimester prenatal diagnosis and detection of carriers of haemophilia A using the linked DNA probe DX13.. BMJ. 291(6498). 765–769. 24 indexed citations
17.
Davies, Kay E., Marie‐Geneviève Mattéi, J. F. Mattéi, et al.. (1985). Linkage studies of X-linked mental retardation: High frequency of recombination in the telomeric region of the human X chromosome (fragile site/linkage/recombination/X chromosome). Human Genetics. 70(3). 249–55. 60 indexed citations
18.
Davies, Kay E., Katherine L. Harper, David T. Bonthron, et al.. (1984). Use of a chromosome 21 cloned DNA probe for the analysis of non-disjunction in Down syndrome. Human Genetics. 66(1). 54–56. 54 indexed citations
19.
Harper, Katherine L., Marcus Pembrey, K.E. Davies, et al.. (1984). A CLINICALLY USEFUL DNA PROBE CLOSELY LINKED TO HAEMOPHILIA A. The Lancet. 324(8393). 6–8. 83 indexed citations
20.
Harper, Katherine L., et al.. (1978). Thin-layer chromatographic system for identification and quantitation of potato tuber glycoalkaloids. Journal of Agricultural and Food Chemistry. 26(6). 1453–1454. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026